AIA Group Ltd Has $3.31 Million Stake in CME Group Inc. (NASDAQ:CME)

AIA Group Ltd grew its stake in CME Group Inc. (NASDAQ:CME) by 109.0% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 15,392 shares of the financial services provider’s stock after purchasing an additional 8,027 shares during the period. AIA Group Ltd’s holdings in CME Group were worth $3,314,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of CME. Second Half Financial Partners LLC bought a new position in CME Group during the 4th quarter valued at about $2,737,000. Naples Global Advisors LLC lifted its holdings in CME Group by 5.6% during the 4th quarter. Naples Global Advisors LLC now owns 2,072 shares of the financial services provider’s stock valued at $436,000 after purchasing an additional 110 shares during the last quarter. Sapient Capital LLC bought a new position in CME Group during the 4th quarter valued at about $1,823,000. Raymond James Financial Services Advisors Inc. lifted its holdings in CME Group by 2.3% during the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 1,041,526 shares of the financial services provider’s stock valued at $224,230,000 after purchasing an additional 23,340 shares during the last quarter. Finally, Bluefin Capital Management LLC bought a new position in shares of CME Group in the fourth quarter worth about $2,891,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.

CME Group Stock Down 1.2 %

Shares of CME Group stock traded down $2.37 on Friday, hitting $193.43. The company had a trading volume of 3,124,714 shares, compared to its average volume of 1,969,101. The firm has a market capitalization of $69.65 billion, a P/E ratio of 22.01, a P/E/G ratio of 5.11 and a beta of 0.52. CME Group Inc. has a twelve month low of $180.88 and a twelve month high of $223.80. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.01. The stock has a 50-day moving average of $202.15 and a 200-day moving average of $207.48.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, April 24th. The financial services provider reported $2.50 earnings per share for the quarter, beating the consensus estimate of $2.44 by $0.06. The company had revenue of $1.49 billion during the quarter, compared to analysts’ expectations of $1.48 billion. CME Group had a net margin of 56.84% and a return on equity of 12.45%. The business’s quarterly revenue was up 3.2% compared to the same quarter last year. During the same quarter in the prior year, the company earned $2.42 earnings per share. Research analysts predict that CME Group Inc. will post 9.74 earnings per share for the current year.

CME Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Stockholders of record on Friday, June 7th were given a $1.15 dividend. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.38%. The ex-dividend date was Friday, June 7th. CME Group’s dividend payout ratio is presently 52.33%.

Insider Transactions at CME Group

In other CME Group news, Director Daniel R. Glickman sold 650 shares of the company’s stock in a transaction on Thursday, June 6th. The shares were sold at an average price of $201.44, for a total transaction of $130,936.00. Following the sale, the director now directly owns 14,008 shares of the company’s stock, valued at $2,821,771.52. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, Director Daniel R. Glickman sold 650 shares of the stock in a transaction dated Thursday, June 6th. The shares were sold at an average price of $201.44, for a total value of $130,936.00. Following the transaction, the director now directly owns 14,008 shares of the company’s stock, valued at $2,821,771.52. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Charles P. Carey sold 3,000 shares of the stock in a transaction dated Thursday, June 13th. The shares were sold at an average price of $195.44, for a total transaction of $586,320.00. Following the completion of the transaction, the director now directly owns 7,163 shares in the company, valued at $1,399,936.72. The disclosure for this sale can be found here. Insiders have sold a total of 54,290 shares of company stock valued at $11,393,700 over the last 90 days. 0.30% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on CME. Barclays dropped their target price on shares of CME Group from $228.00 to $208.00 and set an “equal weight” rating for the company in a research note on Wednesday. Bank of America lifted their price target on shares of CME Group from $209.00 to $216.00 and gave the stock a “neutral” rating in a research report on Thursday, April 25th. Morgan Stanley lifted their price target on shares of CME Group from $222.00 to $225.00 and gave the stock an “equal weight” rating in a research report on Tuesday, April 9th. JPMorgan Chase & Co. cut shares of CME Group from a “neutral” rating to an “underweight” rating and lowered their price target for the stock from $206.00 to $187.00 in a research report on Friday, June 21st. Finally, Piper Sandler lowered their price target on shares of CME Group from $250.00 to $235.00 and set an “overweight” rating for the company in a research report on Tuesday. Three research analysts have rated the stock with a sell rating, six have assigned a hold rating and three have given a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $215.82.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.